Microba Life Sciences raises successful $30Mn IPO
Microba Life Sciences Limited is an Australian-based commercial-stage company with leading technology for measuring the human gut microbiome. The firm commenced trading on the Australian Securities Exchange (ASX) at 10.30 am (Sydney, Australia time) recently following the completion of an initial public offering (IPO). According to industrial sources, the overall IPO that was raised was […]
